Circulating biomarkers improve prediction of postoperative outcome after aortic valve surgery - Takeaways - MDSpire

Circulating biomarkers improve prediction of postoperative outcome after aortic valve surgery

  • By

  • Till Joscha Demal

  • Jenny Bialczak

  • Alina Goßling

  • Francisco Miguel Ojeda

  • Oliver Daniel Bhadra

  • Björn Sill

  • Johannes Petersen

  • Sebastian Ludwig

  • David Grundmann

  • Lisa Voigtländer

  • Lara Waldschmidt

  • Laura Hannen

  • Niklas Schofer

  • Stefan Blankenberg

  • Paulus Kirchhof

  • Thomas Renné

  • Lenard Conradi

  • Hermann Reichenspurner

  • Evaldas Girdauskas

  • Andreas Schaefer

  • June 2, 2026

  • 0 min

Share

  • 1

    The study included 492 patients who underwent aortic valve surgery between March 2018 and May 2022.

  • 2

    Preoperative biomarkers such as hemoglobin, creatinine, and high-sensitivity troponin I were analyzed for their association with postoperative outcomes.

  • 3

    Logistic regression showed that several biomarkers were independently associated with 30-day mortality after adjusting for EuroSCORE-II.

  • 4

    Models combining biomarkers with EuroSCORE-II outperformed those using either alone in predicting mortality.

  • 5

    The findings suggest that integrating biomarkers may enhance decision-making for surgical versus transcatheter aortic valve replacement.

Original Source(s)

Related Content